Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function-Reference-Cited by-同舟云学术

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function

Published:2002-07 Issue:5 Volume:12 Page:395-405
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Leabman Maya K.,Huang Conrad C.,Kawamoto Michiko,Johns Susan J.,Stryke Douglas,Ferrin Thomas E.,DeYoung Joseph,Taylor Travis,Clark Andrew G.,Herskowitz Ira,Giacomini Kathleen M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference30 articles.

1. The legacy of pharmacogenetics and potential applications

2. Structure of renal organic anion and cation transporters

3. Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transporters

4. Disposition of metformin (N,N-dimethylbiguanide) in man

5. Aging and renal clearance of procainamide and acetylprocainamide

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of human-specific amino acid residues governing atenolol transport via organic cation transporter 2;Biochemical Pharmacology;2024-11

2. Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3;Journal of Medicinal Chemistry;2023-12-05

3. Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain;Translational Psychiatry;2023-09-29

4. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis;Frontiers in Public Health;2023-07-21

5. Genetic variation in organic cation transporters and considerations in drug development;Expert Opinion on Drug Metabolism & Toxicology;2023-03-04